Pharmaceutical Discovery

Twist Bioscience CEO, cofounder, and director Emily Leproust discusses the company's work and the promising future of synthetic biology.

Suddenly, synthetic biology is being discussed a lot beyond the walls of academia and the pages of scientific journals. Today, it abounds in the mainstream press.

Hear Ryan's perspective on what advances he thinks chemical engineering has ahead of it.

A new experimental broad-spectrum antiviral drug could be used to combat the type of virus that causes the common cold and pneumonia, as well as more lethal viruses such as SARS and MERS.

Technique allows for the observation of how cells and molecules react in their natural environment, presenting possibilities for biomedical and pharmaceutical applications.

An international team of researchers has created new antiviral nanoparticles that show potential for outperforming current antiviral drugs.

Researchers at the University of Nebraska-Lincoln have uncovered clues about how the Zika virus became much more dangerous in recent years.

Researchers have identified an inherited genetic variation that they believe helps identify those at the highest risk for potentially fatal influenza infections.

A new technique labels gene segments to help understand how the virus enters a cell and establishes co-infections.

The failure rate for new drugs and therapies under development exceeds 95%.

A compound found in a snail's venom yields pain-fighting effects in testing, presenting a possible opioid alternative.

Researchers at Indiana University Bloomington have discovered that a molecule related to some forms of cancer and neurodegenerative disorders is also present in developing Drosophila

Researchers at the University of Michigan have had a significant breakthrough in creating a customized therapeutic vaccine for treating colon and melanoma cancer tumors in mice.

Researchers at the University of California, Riverside, recently published work that suggests that the usefulness of studying pro- and anti-apoptotic proteins in a search for cancer

The 2016 D.I.C.

By Dr. Jyotika Virmani

It sounds like something straight out of a science fiction movie: bacteria that feeds on human flesh.